Riskpilot← Back to searchSign inGet full accessFermHub Zealand ApS
APSActiveCVR 41012498Algade 2DManufacture of homogenised food preparations and dietetic food · NACE 1086Est. 20195 employees
Revenue 2024
DKK 7,3M
-32% vs 2023
EBITDA margin
78.5%
-31% vs 2023
Equity ratio
71.5%
Financial strength
Net profit 2024
DKK 4,6M
-29% vs 2023
| Revenue | DKK 7,3M | -32% |
| EBITDA | DKK 5,7M | -31% |
| Net profit | DKK 4,6M | -29% |
| Total assets | DKK 15,3M | +62% |
| Equity | DKK 10,9M | +73% |
| Employees | 5 | — |
Legal name
FermHub Zealand ApS
CVR number
41012498
Legal form
Anpartsselskab
NACE code
1086 · Manufacture of homogenised food preparations and dietetic food
Founded
16. december 2019
Share capital
DKK 40.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af tre bestyrelsesmedlemmer i forening, eller af bestyrelsesformanden i forening med en direktør.
Company purpose
Selskabets formål er at drive produktions- og servicevirksomhed, navnlig inden for industriel biofermentering, og hertil relaterede aktiviteter
Address
Algade 2D
Phone
+4526200202
Email
info@fermhubzealand.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -16 | -45 | 1.041 | 10.672 | 7.269 |
| Staff expenses | -0 | -0 | -1.176 | -2.447 | -1.561 |
| EBITDA | -16 | -45 | -135 | 8.225 | 5.708 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -120 |
| EBIT | -16 | -45 | -135 | 8.225 | 5.587 |
| Net financials | -0 | -1 | -3 | 1 | -60 |
| Profit before tax | -16 | -46 | -138 | 8.225 | 5.527 |
| Tax | -0 | -0 | -0 | 1.747 | 900 |
| Net profit | -16 | -46 | -138 | 6.478 | 4.628 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 49 | 363 | 1.355 | 9.476 | 15.314 |
| Equity | 24 | -22 | -160 | 6.318 | 10.946 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25 | 386 | 1.515 | 1.411 | 1.722 |
| Total debt | 25 | 386 | 1.515 | 1.411 | 1.722 |
EBITDA margin
78.5%
This company
15.8%
Market median
+397% vs market
20202024
Equity ratio
71.5%
This company
38.2%
Market median
+87% vs market
20202024
Return on equity
42.3%
This company
18.4%
Market median
+130% vs market
20202024
Net profit margin
63.7%
This company
8.1%
Market median
+686% vs market
20202024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20202024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-12-16 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LH Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
SA Management | Management | 2019 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2019 | |
| Company | 50–66.65% | 50–66.65% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NatuRem Bioscience ApS
FermHub Zealand ApS Board members of FermHub Zealand ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Allan Brock | Management | 0 companies |
| Lulu Harms Larsen | Chief Executive Officer | 0 companies |
| Christopher Kjølby Jensen | Chairman | 0 companies |
| Christian Kjølby | Board of Directors | 0 companies |